stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Lakewood Amedex Biotherapeutics IncLABT
$0.244915.03%0.032

Lakewood Amedex Biotherapeutics Inc (LABT)

Lakewood Amedex Biotherapeutics Inc stock is traded at $0.2449, with a volume of 57,295,004. It is up +15.03% in the last 24 hours and down -57.59% over the past month. Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.
Previous Close:
$0.2129
Open:
$0.2322
24h Volume:
57,295,004
Relative Volume:
6.38
Market Cap:
$580.34K
Revenue:
-
Net Income/Loss:
-$4.23M
P/E Ratio:
-
EPS:
-$8.80
Net Cash Flow:
-$1.89M
1W Performance:
-13.28%
1M Performance:
-57.59%
6M Performance:
-96.75%
1Y Performance:
0.00%
1-Day Range:
$0.221$0.3072
1-Week Range:
$0.1917$0.3078
52-Week Range:
$0.1687$98.20

Lakewood Amedex Biotherapeutics Inc Stock (LABT) Company Profile

Name
Lakewood Amedex Biotherapeutics Inc
Phone
(941) 225-2515
Address
8031 COOPER CREEK BLVD., UNIVERSITY PARK, USA
Employee
5
X
-
Next Earnings Date
-
Latest SEC Filings
SEC
LABT's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Lakewood Amedex Biotherapeutics Inc Stock (LABT) Financials Data

Similar to LABT